Literature DB >> 16937439

Virological course of hepatitis A virus as determined by real time RT-PCR: Correlation with biochemical, immunological and genotypic profiles.

Zahid Hussain1, Bhudev C Das, Syed A Husain, Sunil K Polipalli, Tanzeel Ahmed, Nargis Begum, Subhash Medhi, Alice Verghese, Mohammad Raish, Apiradee Theamboonlers, Yong Poovorawan, Premashis Kar.   

Abstract

AIM: To undertake analysis of hepatitis A viral load, alanine aminotransferase (ALT), and viral genotypes with duration of viremia, and to correlate these parameters with CD4(+)/ CD8(+) lymphocyte populations that control cell-mediated immunity.
METHODS: Cell counts were carried out using fresh whole blood collected in EDTA vials using a fluorescence activated cell sorter. Hepatitis A virus (HAV) RNA was extracted from blood serum, reverse transcribed into cDNA and quantified by Real-Time polymerase chain reaction and was genotyped.
RESULTS: Among 11 patients, 10 could be analyzed completely. Of these, 3 had severe acute hepatitis (s-AH) and the remainder had a self-limited acute hepatitis A (AHA), with one patient with fulminant disease (encephalopathy Grade IV) dying on the 4th d. The ALT level was significantly higher both in AHA (1070.9 +/- 894.3; P = 0.0014) and s-AH (1713.9 +/- 886.3; P = 0.001) compared to normal controls (23.6 +/- 7.2). The prothrombin time in s-AH patients (21.0 +/- 2.0; P = 0.02) was significantly higher than in AHA (14.3 +/- 1.1; P = 0.44). The CD4(+)/CD8(+) ratio in AHA patients (1.17 +/- 0.11; P = 0.22) and s-AH (0.83 +/- 0.12; P = 0.0002) were lower than seen in normal healthy controls (1.52). Self-limited cases had peak viral load at the beginning of analysis while in s-AH patients this occurred at the 15th or 30th d. In acute and severe groups, one patient each belonged to genotype IA, with the remaining 8 cases belonging to genotype IIIA. The only fulminant hepatic failure case belonged to genotype IA. HAV viral load and ALT values collected during the entire course of the self-limited infection were directly correlated but this was not the case for s-AH patients.
CONCLUSION: Based on a small-scale study, the persistently higher viral load of s-AH might be due to diminished cellular immunity and hemolysis. The duration of viremia was dependent on the host, as the viral genotype had no apparent role in clinical outcome of AVH and s-AH cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937439      PMCID: PMC4087833          DOI: 10.3748/wjg.v12.i29.4683

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  35 in total

1.  Quantification of enterovirus RNA in sludge samples using single tube real-time RT-PCR.

Authors:  S Monpoeho; A Dehée; B Mignotte; L Schwartzbrod; V Marechal; J C Nicolas; S Billaudel; V Férré
Journal:  Biotechniques       Date:  2000-07       Impact factor: 1.993

2.  Detection of hepatitis A virus RNA in commercially available factor VIII preparation.

Authors:  A Normann; J Graff; A Gerritzen; H H Brackmann; B Flehmig
Journal:  Lancet       Date:  1992-11-14       Impact factor: 79.321

3.  Immunological studies in an epidemic of infective, short-incubation hepatitis.

Authors:  A B Ajdukiewicz; R A Fox; F J Dudley; D Doniach; S Sherlock
Journal:  Lancet       Date:  1972-04-15       Impact factor: 79.321

4.  Complete nucleotide sequence of a cell culture-adapted variant of hepatitis A virus: comparison with wild-type virus with restricted capacity for in vitro replication.

Authors:  R W Jansen; J E Newbold; S M Lemon
Journal:  Virology       Date:  1988-04       Impact factor: 3.616

5.  Liver-derived cytotoxic T cells in hepatitis A virus infection.

Authors:  A Vallbracht; K Maier; Y D Stierhof; K H Wiedmann; B Flehmig; B Fleischer
Journal:  J Infect Dis       Date:  1989-08       Impact factor: 5.226

6.  Frequent detection of hepatitis A viral RNA in serum during the early convalescent phase of acute hepatitis A.

Authors:  K Fujiwara; O Yokosuka; T Ehata; F Imazeki; H Saisho; M Miki; M Omata
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

7.  Chronic hepatitis A with persistent viral replication.

Authors:  K Inoue; M Yoshiba; H Yotsuyanagi; T Otsuka; K Sekiyama; R Fujita
Journal:  J Med Virol       Date:  1996-12       Impact factor: 2.327

Review 8.  Risk of hepatitis A in travellers.

Authors:  R Steffen
Journal:  Vaccine       Date:  1992       Impact factor: 3.641

9.  Time course of hepatitis A viremia and viral load in the blood of human hepatitis A patients.

Authors:  Andrea Normann; Christian Jung; Angelika Vallbracht; Bertram Flehmig
Journal:  J Med Virol       Date:  2004-01       Impact factor: 2.327

10.  Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells.

Authors:  I Kurane; L N Binn; W H Bancroft; F A Ennis
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

View more
  3 in total

1.  Immunological and molecular epidemiological characteristics of acute and fulminant viral hepatitis A.

Authors:  Zahid Hussain; Syed A Husain; Fahad N Almajhdi; Premashis Kar
Journal:  Virol J       Date:  2011-05-23       Impact factor: 4.099

2.  Longitudinal Study of Hepatitis A Infection by Saliva Sampling: The Kinetics of HAV Markers in Saliva Revealed the Application of Saliva Tests for Hepatitis A Study.

Authors:  Luciane Almeida Amado Leon; Adilson José de Almeida; Vanessa Salete de Paula; Renata Santos Tourinho; Daniel Antunes Maciel Villela; Ana Maria Coimbra Gaspar; Lia Laura Lewis-Ximenez; Marcelo Alves Pinto
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

Review 3.  Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review.

Authors:  Kuan-Yin Lin; Guan-Jhou Chen; Yu-Lin Lee; Yi-Chia Huang; Aristine Cheng; Hsin-Yun Sun; Sui-Yuan Chang; Chun-Eng Liu; Chien-Ching Hung
Journal:  World J Gastroenterol       Date:  2017-05-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.